SK251992A3 - Methanoanthracene derivatives, process for their preparation, intermediates for their preparation and pharmaceutical compositions containing mentioned derivatives - Google Patents

Methanoanthracene derivatives, process for their preparation, intermediates for their preparation and pharmaceutical compositions containing mentioned derivatives Download PDF

Info

Publication number
SK251992A3
SK251992A3 SK2519-92A SK251992A SK251992A3 SK 251992 A3 SK251992 A3 SK 251992A3 SK 251992 A SK251992 A SK 251992A SK 251992 A3 SK251992 A3 SK 251992A3
Authority
SK
Slovakia
Prior art keywords
group
dihydro
formula
ylmethyl
alkyl
Prior art date
Application number
SK2519-92A
Other languages
English (en)
Slovak (sk)
Other versions
SK280356B6 (sk
Inventor
Robert T Jacobs
Michael T Klimas
Cyrus J Ohnmacht
Marc O Terpko
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of SK280356B6 publication Critical patent/SK280356B6/sk
Publication of SK251992A3 publication Critical patent/SK251992A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/48Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/52Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SK2519-92A 1991-08-15 1992-08-14 Methanoanthracene derivatives, process for their preparation, intermediates for their preparation and pharmaceutical compositions containing mentioned derivatives SK251992A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919117639A GB9117639D0 (en) 1991-08-15 1991-08-15 Therapeutic compounds

Publications (2)

Publication Number Publication Date
SK280356B6 SK280356B6 (sk) 1999-12-10
SK251992A3 true SK251992A3 (en) 1999-12-10

Family

ID=10700033

Family Applications (1)

Application Number Title Priority Date Filing Date
SK2519-92A SK251992A3 (en) 1991-08-15 1992-08-14 Methanoanthracene derivatives, process for their preparation, intermediates for their preparation and pharmaceutical compositions containing mentioned derivatives

Country Status (25)

Country Link
EP (1) EP0533344B1 (de)
JP (1) JP2889056B2 (de)
KR (1) KR100245955B1 (de)
AT (1) ATE144253T1 (de)
AU (1) AU658905B2 (de)
BG (1) BG61893B2 (de)
CA (1) CA2076191A1 (de)
CZ (1) CZ283848B6 (de)
DE (1) DE69214588T2 (de)
DK (1) DK0533344T3 (de)
ES (1) ES2092646T3 (de)
FI (1) FI102964B (de)
GB (2) GB9117639D0 (de)
GR (1) GR3021398T3 (de)
HK (1) HK83697A (de)
HU (2) HUT66625A (de)
IE (1) IE922588A1 (de)
IL (1) IL102807A (de)
NO (1) NO301008B1 (de)
NZ (1) NZ243955A (de)
RU (1) RU2099328C1 (de)
SG (1) SG48140A1 (de)
SK (1) SK251992A3 (de)
TW (1) TW221808B (de)
ZA (1) ZA926148B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9216297D0 (en) * 1991-08-15 1992-09-16 Ici Plc Therapeutic agents
GB9216298D0 (en) * 1991-08-15 1992-09-16 Ici Plc Piperidine derivatives
GB9314250D0 (en) * 1993-07-09 1993-08-18 Zeneca Ltd Piperidinyl compounds
CA2181759A1 (en) * 1995-07-26 1997-01-27 Mira A. Kanzelberger (thiophen-2-yl)-piperidin or tetrahydropyridin azabicyclocarboxamides
US6211199B1 (en) 1995-11-17 2001-04-03 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
US6423704B2 (en) 1995-12-20 2002-07-23 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases
US6194406B1 (en) 1995-12-20 2001-02-27 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic disease
US5998439A (en) * 1996-02-21 1999-12-07 Hoescht Marion Roussel, Inc. Substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
US5932571A (en) * 1996-02-21 1999-08-03 Hoechst Marion Roussel, Inc. Substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl) {1,4}diazepan-1-yl)-2-(aryl) butyl) benzamides useful for the treatment of allergic diseases
US5922737A (en) * 1996-02-21 1999-07-13 Hoechst Marion Roussel, Inc. Substituted N-methyl-N-(4-(4-(1H-Benzimidazol-2-YL-amino) piperidin-1-YL)-2-(arlyl) butyl) benzamides useful for the treatment of allergic diseases
TW200626572A (en) 2004-09-20 2006-08-01 Xenon Pharmaceuticals Inc Heterocyclic derivatives and their use as therapeutic agents
BRPI0515483A (pt) 2004-09-20 2008-07-22 Xenon Pharmaceuticals Inc derivados heterocìclicos para o tratamento de doenças mediadas por enzimas estearoil-coa desaturase
WO2006034440A2 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
MX2007003332A (es) 2004-09-20 2007-06-05 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como inhibidores de estearoil-coa-desaturasa.
EP1814551A2 (de) 2004-09-20 2007-08-08 Xenon Pharmaceuticals Inc. Pyridazin-derivate zur verhinderung menschlicher stearoyl-coa-desaturase
BRPI0515488A (pt) 2004-09-20 2008-07-29 Xenon Pharmaceuticals Inc derivados de heterocìclicos e seu uso como agentes terapêuticos
TW200626139A (en) 2004-09-20 2006-08-01 Xenon Pharmaceuticals Inc Heterocyclic derivatives and their use as therapeutic agents
EP2540296A1 (de) 2005-06-03 2013-01-02 Xenon Pharmaceuticals Inc. Arminothiazolderivate als menschliche Stearoyl-Coa-Desaturase-Hemmer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5911576B2 (ja) * 1975-07-07 1984-03-16 住友化学工業株式会社 新規なメタノ−アントラセン誘導体の製造法
US4358620A (en) * 1974-12-13 1982-11-09 Sumitomo Chemical Company, Limited 9-Formyl-9,10-dihydro-9,10-methanoanthracene
GB1508669A (en) * 1974-12-13 1978-04-26 Sumitomo Chemical Co Methanoanthracene derivative and a process for the preparation thereof
GB1531278A (en) * 1975-12-15 1978-11-08 Shionogi & Co 9,10-dihydro-9,10-methanoanthracene n-oxide derivatives and the production thereof
JPS5910654B2 (ja) * 1976-04-07 1984-03-10 住友化学工業株式会社 新規なメタノ−アントラセン誘導体

Also Published As

Publication number Publication date
ES2092646T3 (es) 1996-12-01
CZ283848B6 (cs) 1998-06-17
NO923199D0 (no) 1992-08-14
TW221808B (de) 1994-03-21
FI102964B1 (fi) 1999-03-31
AU2101492A (en) 1993-02-18
IL102807A0 (en) 1993-01-31
IL102807A (en) 1998-08-16
JP2889056B2 (ja) 1999-05-10
GB9117639D0 (en) 1991-10-02
KR100245955B1 (ko) 2000-04-01
FI923663A (fi) 1993-02-16
JPH05213872A (ja) 1993-08-24
SK280356B6 (sk) 1999-12-10
CZ251992A3 (en) 1993-02-17
HUT66625A (en) 1994-12-28
KR930004262A (ko) 1993-03-22
NO923199L (no) 1993-02-16
RU2099328C1 (ru) 1997-12-20
HU211661A9 (en) 1995-12-28
AU658905B2 (en) 1995-05-04
CA2076191A1 (en) 1993-02-16
ATE144253T1 (de) 1996-11-15
HU9202643D0 (en) 1992-10-28
GR3021398T3 (en) 1997-01-31
DE69214588T2 (de) 1997-05-28
NO301008B1 (no) 1997-09-01
DE69214588D1 (de) 1996-11-21
FI102964B (fi) 1999-03-31
EP0533344A1 (de) 1993-03-24
NZ243955A (en) 1995-10-26
BG61893B2 (bg) 1998-08-31
HK83697A (en) 1997-06-27
SG48140A1 (en) 1998-04-17
ZA926148B (en) 1993-04-28
GB9216296D0 (en) 1992-09-16
IE922588A1 (en) 1993-02-24
DK0533344T3 (de) 1997-03-03
FI923663A0 (fi) 1992-08-14
EP0533344B1 (de) 1996-10-16

Similar Documents

Publication Publication Date Title
SK251992A3 (en) Methanoanthracene derivatives, process for their preparation, intermediates for their preparation and pharmaceutical compositions containing mentioned derivatives
RU2411237C2 (ru) ПРОИЗВОДНЫЕ ПИРИДИН-2-КАРБОКСАМИДА В КАЧЕСТВЕ АНТАГОНИСТОВ mGluR5
KR100360633B1 (ko) Nos 억제제로서 유용한 6-페닐피리딜-2-아민 유도체
DE60112791T2 (de) Piperidin mch antagonisten und ihre verwendung in der behandlung von obesität
US5512575A (en) Methanoanthraceneyl methyl piperidinyl compounds
US5849765A (en) Tetrahydropyridine derivatives as dopamine receptor subtype ligands
JP3281047B2 (ja) メタノアントラセン化合物、該化合物を含有する神経精神障害治療用薬剤組成物、該化合物の製造方法及び該化合物を製造するための中間体
JP3031634B2 (ja) D1アンタゴニスト/d2アンタゴニスト及び5ht2−セロトニンアンタゴニストとしてのピペリジニル置換メタノアントラセン